Avigen Reports Third Quarter 2008 Financial Results
Avigen, Inc., a biopharmaceutical company innovating therapeutics for neurological care, reported financial results. Avigen had approximately $56 million in financial assets, including cash, cash equivalents, and available-for-sale securities and restricted investments, compared with approximately $78 million at December 31, 2007. [more...]
|
|
|
